| Literature DB >> 28794410 |
Ruoxi Dai1,2, Otto L T Lam3, Edward C M Lo1, Leonard S W Li4, Colman McGrath5.
Abstract
This study was to evaluate the effectiveness of oral hygiene care in improving oral health- and health-related quality of life (OHRQoL and HRQoL) among patients receiving outpatient stroke rehabilitation. Subjects were randomized to: (1) a conventional oral hygiene care programme (COHCP) comprising a manual toothbrush, and oral hygiene instruction, or (2) an advanced oral hygiene care programme (AOHCP) comprising a powered toothbrush, 0.2% chlorhexidine mouthrinse, and oral hygiene instruction. The interventional period lasted for 3 months, followed by a 3-month observational period. HRQoL was assessed by SF-12, and OHRQoL was assessed by Oral Health Impact Profile-14 (OHIP-14), General Oral Health Assessment Index (GOHAI), and Oral Health Transitional Scale (OHTS). Participants in AOHCP group had significantly better OHRQoL at the end of clinical trial as assessed by OHTS (p < 0.01), and at the end of observational study as assessed by GOHAI (p < 0.05) than those in the COHCP. Participants in the AOHCP group had significantly better HRQoL as assessed by physical component summary score (PCS) the end of both 3 and 6 months (both p < 0.05). This study provided the evidence that the AOHCP was more effective than the COHCP within stroke rehabilitation in improving subjective health.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28794410 PMCID: PMC5550442 DOI: 10.1038/s41598-017-07666-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow diagram of numbers of patients undergoing stroke rehabilitation in different stages of the study.
Factors associated with GOHAI (linear regression). 3-month final model: adjusted R square = 0.64. 6-month final model: adjusted R square (model 3) = 0.57.
| Model | Variable | Unstandardized coefficient | SE | Standardized coefficient | p-value | Collinearity statistics | |
|---|---|---|---|---|---|---|---|
| Tolerance | VIF | ||||||
|
| Intervention | −1.05 | 0.68 | −0.1 | 0.13 | 1 | 1 |
| GOHAI baseline | 0.65 | 0.06 | 0.74 | <0.001 | 0.97 | 1.03 | |
| Plaque baseline | −0.06 | 1.8 | −0.2 | <0.01 | 0.97 | 1.03 | |
|
| Intervention | −1.91 | 0.8 | −0.16 | 0.019 | 1 | 1 |
| GOHAI baseline | 0.67 | 0.07 | 0.7 | <0.001 | 0.97 | 1.03 | |
| Plaque baseline | −0.05 | 0.02 | −0.17 | 0.016 | 0.97 | 1.03 | |
Factors associated with OHIP-14 (negative binomial regression). 3-month final model: Omnibus Test: p < 0.001; Goodness of fit: deviance/df = 0.75; Pearson Chi-square/df = 0.66. 6-month final model: Omnibus Test: p = 0.003; Goodness of fit: deviance/df = 1.14; Pearson Chi-square/df = 0.73.
| Model | Variable | IRR | SE | p-value |
|---|---|---|---|---|
|
| Intervention | 1.13 | 0.18 | 0.47 |
| OHIP-14 baseline | 1.11 | 0.01 | <0.001 | |
|
| Intervention | 1.26 | 0.23 | 0.19 |
| OHIP-14 baseline | 1.1 | 0.37 | <0.001 |
Factors associated with OHTS (linear regression).
| Model | Variable | Unstandardized coefficient | SE | Standardized coefficient | p-value | Collinearity statistics | |
|---|---|---|---|---|---|---|---|
| Tolerance | VIF | ||||||
|
| Intervention | 0.82 | 0.30 | 0.19 | 0.007< | 0.97 | 1.04 |
| OHTS baseline | 0.66 | 0.06 | 0.71 | <0.001 | 0.98 | 1.03 | |
| Comorbidities | 0.43 | 0.16 | 0.18 | 0.010 | 0.97 | 1.03 | |
| Denture | 0.83 | 0.36 | 0.16 | 0.024 | 0.99 | 1.01 | |
|
| Intervention | 0.64 | 0.36 | 0.14 | 0.08 | 0.97 | 1.03 |
| OHTS baseline | 0.60 | 0.08 | 0.63 | <0.001 | 0.98 | 1.03 | |
| Comorbidities | 0.40 | 0.19 | 0.17 | 0.04 | 0.97 | 1.03 | |
3-month model: adjusted R square = 0.64. 6-month model: adjusted R square = 0.64.
Factors associated with PCS scores (linear regression model).
| Model | Variable | Unstandardized coefficient | SE | Standardized coefficient | p-value | Collinearity statistics | |
|---|---|---|---|---|---|---|---|
| Tolerance | VIF | ||||||
|
| |||||||
|
| Intervention | −3.31 | 1.47 | −0.19 | 0.027 | 1.00 | 1.00 |
| PCS baseline | 0.53 | 0.10 | 0.45 | <0.001 | 0.93 | 1.08 | |
| GOHAI baseline | 0.34 | 0.12 | 0.24 | 0.007 | 0.93 | 1.07 | |
|
| Intervention | −3.63 | 1.49 | −0.21 | 0.017 | 0.99 | 1.01 |
| PCS baseline | 0.56 | 0.10 | 0.48 | <0.001 | 0.96 | 1.04 | |
| OHIP baseline | −0.26 | 0.11 | −0.21 | 0.018 | 0.96 | 1.04 | |
|
| |||||||
|
| Intervention | −3.92 | 1.80 | −0.21 | 0.032 | 1.00 | 1.00 |
| GOHAI baseline | 0.39 | 0.15 | 0.26 | 0.011 | 0.93 | 1.07 | |
| PCS baseline | 0.29 | 0.13 | 0.23 | 0.025 | 0.93 | 1.08 | |
|
| Intervention | −4.35 | 1.80 | −0.23 | 0.018 | 0.99 | 1.01 |
| OHIP-14 baseline | −0.34 | 0.13 | −0.26 | 0.010 | 0.96 | 1.04 | |
| PCS baseline | 0.31 | 0.12 | 0.24 | 0.014 | 0.96 | 1.04 | |
3-month final model: adjusted RP Psquare (model 3a) = 0.33; adjusted R square (model 3b) = 0.31. 6-month final model: adjusted RP Psquare (model 3a) = 0.16; adjusted R square (model 3b) = 0.16.
Factors associated with MCS scores (linear regression model). 3-month model: adjusted R square = 0.45. 6-month model: adjusted R square = 0.37.
| Model | Variable | Unstandardized coefficient | SE | Standardized coefficient | p-value | Collinearity statistics | |
|---|---|---|---|---|---|---|---|
| Tolerance | VIF | ||||||
|
| Intervention | 0.02 | 1.55 | 0.01 | 0.99 | 0.98 | 1.02 |
| MCS baseline | 0.58 | 0.07 | 0.66 | <0.001 | 1 | 1 | |
| Comorbidities | −2.04 | 0.84 | −0.19 | 0.017 | 0.98 | 1.02 | |
|
| Intervention | 0.15 | 1.68 | 0.01 | 0.93 | 0.97 | 1.03 |
| MCS baseline | 0.5 | 0.08 | 0.56 | <0.001 | 0.96 | 1.04 | |
| Comorbidities | −3.8 | 0.93 | −0.35 | <0.001 | 0.94 | 1.06 | |
| Brushing habit | 6.17 | 1.94 | 0.28 | 0.002 | 0.91 | 1.1 | |